Bed Bath & Beyond, Inc.

NYSE:BBBY Voorraadrapport

Marktkapitalisatie: US$391.9m

Bed Bath & Beyond Toekomstige groei

Future criteriumcontroles 3/6

De verwachting is dat Bed Bath & Beyond de winst en omzet met respectievelijk 61.6% en 8.9% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 63.3% per jaar.

Belangrijke informatie

61.6%

Groei van de winst

63.32%

Groei van de winst per aandeel

Specialty Retail winstgroei9.8%
Inkomstengroei8.9%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt28 Apr 2026

Recente toekomstige groei-updates

Analyse-artikel Oct 31

Bed Bath & Beyond, Inc. (NYSE:BBBY) Analysts Are Pretty Bullish On The Stock After Recent Results

Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shareholders are probably feeling a little disappointed, since its shares fell...

Recent updates

Analyse-update May 05

BBBY: Core Business Inflection And SKU Consolidation Will Support Future Repricing

Narrative Update Analysts have maintained their average $7.00 price target on Bed Bath & Beyond, with recent research citing mixed signals. Higher projected revenue growth and a very high future P/E multiple are being weighed against materially lower margin assumptions and ongoing execution uncertainty.
Seeking Alpha Apr 29

Bed Bath & Beyond: Still Unprofitable, Still Burning Through Cash

Summary Bed Bath & Beyond reported another quarter of negative GAAP net losses, heavy dilution, and cash burn. BBBY's revenue grew 7% year-over-year in the first quarter, aided by acquisitions, but gross margin declined 117 basis points to 23.9%. Recent purchases, including The Container Store and F9 Brands assets, are expected to drive revenue through 2026. BBBY is targeting $60 million in cost reductions for 2026, yet dilution and negative operating cash flow overshadow near-term growth prospects. Read the full article on Seeking Alpha
Analyse-update Apr 21

BBBY: Core Business Inflection And SKU Consolidation Will Drive Future Upside

Analysts have trimmed their average price targets for Bed Bath & Beyond to a range of about $7 to $8 from prior levels near $10 to $13, citing a mix of sequential improvement in the core business, cautious views on the execution of internal initiatives, and a valuation reset based on updated EBITDA assumptions. Analyst Commentary Recent research updates highlight that price targets for Bed Bath & Beyond have been pulled back into the high single digits, with analysts pointing to a mix of operational progress and ongoing execution risk.
Analyse-update Apr 07

BBBY: SKU Consolidation And Core Business Inflection Will Support Durable Turnaround

Analysts have trimmed Bed Bath & Beyond's average price target to a range anchored around $7 to $8. This reflects cautious views on execution risks even as they point to early signs of improvement in the core business, including SKU consolidation progress and steadier online trends.
Analyse-update Mar 23

BBBY: Website Momentum And SKU Consolidation Will Support Multiyear Turnaround

Analysts have trimmed their average price target for Bed Bath & Beyond by $0.40. They are tying the shift to mixed Q4 takeaways, where improving core trends and SKU consolidation are being weighed against lower margin expectations and ongoing uncertainty around the multiyear turnaround plan.
Analyse-update Mar 09

BBBY: Lemonis Leadership And SKU Consolidation Will Support Renewed Core Business Momentum

Analysts have trimmed their average price target on Bed Bath & Beyond to a range around $7 to $8, reflecting updated P/E assumptions and caution around execution, even as they point to improving website trends and early traction from internal initiatives such as SKU consolidation. Analyst Commentary Recent research updates show that bearish analysts are trimming price targets even as they acknowledge some operational progress in the core business and on initiatives like SKU consolidation.
Analyse-update Feb 23

BBBY: Website Momentum And 2027 EBITDA Outlook Will Drive Upside Potential

Analysts have trimmed their fair value estimate for Bed Bath & Beyond from $10.90 to $9.80, tying the lower target to a reduced revenue outlook and higher assumed discount rate, partly balanced by expectations for slightly stronger profit margins and a higher future P/E multiple. Analyst Commentary Recent Street research highlights a mix of optimism and caution around Bed Bath & Beyond, with valuation expectations reset lower even as some early signs in the core business draw interest.
Analyse-update Feb 09

BBBY: Leadership Consolidation Under Lemonis Will Support A More Bullish Outlook

Analysts have adjusted their price target on Bed Bath & Beyond to US$7.00, reflecting small tweaks to discount rate, revenue growth, profit margin and future P/E assumptions, while keeping their overall fair value view unchanged at US$7.00. What's in the News On December 30, 2025, Bed Bath & Beyond's Board appointed Executive Chairman and principal executive officer Marcus Lemonis as Chief Executive Officer, effective January 1, 2026.
Analyse-update Jan 25

BBBY: Higher US$8 Outlook And Buybacks Will Shape A Cautious Fairly Valued Path

Narrative Update: Bed Bath & Beyond Analyst Price Target Shift Analysts have lifted their 12 month price target on Bed Bath & Beyond to US$8 from US$5, citing refreshed post earnings models that reflect updated assumptions on discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent commentary highlights that even with the price target increase to US$8, some research views remain cautious.
Analyse-artikel Jan 23

Revenues Not Telling The Story For Bed Bath & Beyond, Inc. (NYSE:BBBY) After Shares Rise 31%

Those holding Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shares would be relieved that the share price has rebounded 31% in...
Analyse-update Jan 11

BBBY: Earnings Refit And Buyback Activity Set A Cautious Path Forward

Analysts lifted their price target on Bed Bath & Beyond to US$8.00 from US$5.00, citing updated earnings assumptions that reflect changes to fair value, discount rate, revenue growth, profit margin and future P/E expectations. Analyst Commentary While the updated price target of US$8.00 reflects refreshed earnings assumptions, bearish analysts still frame the stock as a higher risk proposition rather than a clear upside story.
Analyse-update Dec 14

BBBY: Margin Gains And Buyback Support Brighter Outlook Ahead

Analysts have raised their price target on Bed Bath & Beyond to $8 from $5, citing updated post-earnings models that reflect slightly higher profit margin expectations despite more modest projected revenue growth and a higher assumed future valuation multiple. Analyst Commentary Bearish analysts acknowledged that the higher price target reflects improved margin visibility following the latest earnings update, but they emphasized that the new $8 objective still implies limited upside from current levels.
Analyse-artikel Nov 02

Some Bed Bath & Beyond, Inc. (NYSE:BBBY) Shareholders Look For Exit As Shares Take 36% Pounding

Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shareholders won't be pleased to see that the share price has had a very rough...
Analyse-artikel Oct 31

Bed Bath & Beyond, Inc. (NYSE:BBBY) Analysts Are Pretty Bullish On The Stock After Recent Results

Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shareholders are probably feeling a little disappointed, since its shares fell...
Analyse-artikel Sep 09

Bed Bath & Beyond, Inc.'s (NYSE:BBBY) Shares Climb 31% But Its Business Is Yet to Catch Up

Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shares have continued their recent momentum with a 31% gain in the last month...
Analyse-update Aug 07

E-commerce And Luxury Retail Trends Will Unlock Value

The increase in Beyond's consensus analyst price target from $8.80 to $10.90 is primarily driven by upward revisions in both revenue growth forecasts and future P/E multiples. What's in the News Beyond, Inc.
Analyse-artikel Aug 05

Health Check: How Prudently Does Beyond (NYSE:BYON) Use Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyse-artikel Jul 09

Revenues Not Telling The Story For Beyond, Inc. (NYSE:BYON) After Shares Rise 27%

Despite an already strong run, Beyond, Inc. ( NYSE:BYON ) shares have been powering on, with a gain of 27% in the last...
Analyse-artikel May 13

What Beyond, Inc.'s (NYSE:BYON) 29% Share Price Gain Is Not Telling You

Beyond, Inc. ( NYSE:BYON ) shareholders are no doubt pleased to see that the share price has bounced 29% in the last...
Seeking Alpha Apr 22

Beyond: Liberation Day Could Be A Disaster For Margins

Summary BYON faces severe financial distress with an 83% stock price drop, negative free cash flow, and liquidity issues set to be exacerbated by tariffs. The company's strategy of acquiring failed brands has not succeeded, leading to asset sales and further liquidity concerns amid recession fears. Fiscal 2024 fourth quarter revenue dropped 21.1% over its year-ago comp, missing estimates, with negative adjusted EBITDA and EPS. Liberation Day tariffs, especially a 145% tariff on Chinese imports, pose significant risks, making BYON a sell due to intense cash burn and uncertainty. Read the full article on Seeking Alpha
User avatar
Nieuwe analyse Apr 01

Expense Cuts And Vendor Consolidation Will Streamline Operations

Vendor consolidation and SG&A reductions are poised to enhance profitability and strengthen margins by streamlining operations and costs.
Seeking Alpha Mar 18

Beyond Stock.: Iconic Brands Versus Downward Trending Financials

Summary Beyond, Inc. is in a transition phase, rebranding under Bed Bath & Beyond, and aims to streamline SKUs to improve profitability amid a competitive market. Despite improving net income, Beyond, Inc. reported a 10.6% decline in revenue for 2024, marking the fourth consecutive year of revenue drops. The stock appears cheap with low valuation multiples, but significant risks and ongoing cash flow challenges warrant a cautious "hold" rating. Aggressive cost-cutting and competitive pressures from giants like Amazon and Walmart, along with macroeconomic uncertainties, pose substantial risks to Beyond, Inc.'s turnaround efforts. Read the full article on Seeking Alpha
Analyse-artikel Mar 10

Some Beyond, Inc. (NYSE:BYON) Shareholders Look For Exit As Shares Take 30% Pounding

Beyond, Inc. ( NYSE:BYON ) shares have retraced a considerable 30% in the last month, reversing a fair amount of their...
Seeking Alpha Feb 07

Beyond Inc.: Analysts Overly Pessimistic, Recent Trends Likely To Reverse

Summary Beyond, Inc.'s asset-light model ensures high FCF conversion and positions the company for profitable growth as revenue scales. Leadership under Marcus Lemonis, with equity-based compensation, drives a performance-focused approach, aiming for significant stock price appreciation. Strategic partnerships and private equity investments offer synergies and mispriced optionality, enhancing Beyond's growth potential. Despite past execution missteps and cash burn concerns, market share gains and a stabilizing furniture market present a valuation opportunity. Read the full article on Seeking Alpha
Analyse-artikel Jan 23

After Leaping 43% Beyond, Inc. (NYSE:BYON) Shares Are Not Flying Under The Radar

Beyond, Inc. ( NYSE:BYON ) shares have had a really impressive month, gaining 43% after a shaky period beforehand...
Seeking Alpha Jan 21

Beyond: The Perfect Turnaround Storm Could Be Unfolding

Summary CEO Marcus Lemonis, personally invested $5M, drives a focused KPI-led recovery. Trading at 0.08x EV/revenue, market pricing insolvency, clear turnaround plan, with promising early results. $65M cost cuts mostly realized, paving the path to breakeven FCF by Q3 2025. SKU realignment and targeted marketing address site conversion gaps for revenue lift. Read the full article on Seeking Alpha
Seeking Alpha Nov 13

Is It Beyond Time For Some Changes At Beyond, Inc.?

Summary Executive Chairman Marcus Lemonis has faced criticism for repeated missteps, leading to a 75% decline in BYON shares since he took over. BYON's cash adjusted market cap is down to $135 million, making it both a great acquisition target and a great candidate for a stock buyback. The company's blockchain assets, tZERO and Medici, are significantly more valuable than the retail ops based on current market values and this needs to be communicated to investors. Short interest continues to climb (16.3% of shares), indicating traders expect further declines, but some are expecting a turnaround or acquisition by a strategic investor like Ryan Cohen. Read the full article on Seeking Alpha

Winst- en omzetgroeiprognoses

NYSE:BBBY - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20281,5525N/AN/A1
12/31/20271,578-33-15-73
12/31/20261,370-7128353
3/31/20261,061-61-30-18N/A
12/31/20251,045-85-73-57N/A
9/30/20251,074-145-89-72N/A
6/30/20251,129-202-112-99N/A
3/31/20251,244-225-197-191N/A
12/31/20241,395-259-184-174N/A
9/30/20241,476-339-190-180N/A
6/30/20241,538-341-162-148N/A
3/31/20241,562-371-122-73N/A
12/31/20231,561-308-64-19N/A
9/30/20231,582-164-68-21N/A
6/30/20231,669-138-59-16N/A
3/31/20231,774-56-43-26N/A
12/31/20221,929-37-27-13N/A
9/30/20222,1379216N/A
6/30/20222,36674-150N/A
3/31/20222,6331183852N/A
12/31/20212,7561346781N/A
9/30/20212,8131266881N/A
6/30/20212,842134116129N/A
3/31/20212,814127256270N/A
12/31/20202,49491182196N/A
9/30/20202,19542190206N/A
6/30/20201,825-25136155N/A
3/31/20201,431-95-63-42N/A
12/31/20191,435-62N/A-82N/A
9/30/20191,541-139N/A-108N/A
6/30/20191,635-154N/A-134N/A
3/31/20191,744-193N/A-180N/A
12/31/20181,822-205N/A-139N/A
9/30/20181,825-253N/A-93N/A
6/30/20181,809-207N/A-60N/A
3/31/20181,758-151N/A-22N/A
12/31/20171,745-107N/A-35N/A
9/30/20171,815-11N/A-7N/A
6/30/20171,832-13N/A20N/A
3/31/20171,819-7N/A51N/A
12/31/20161,80013N/A40N/A
9/30/20161,75410N/A75N/A
6/30/20161,70411N/A75N/A
3/31/20161,67313N/A63N/A
12/31/20151,6582N/A55N/A
9/30/20151,6484N/A45N/A
6/30/20151,6107N/A62N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er wordt voorspeld dat BBBY de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 3.5% ).

Winst versus markt: Er wordt verwacht dat BBBY de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.

Hoge groeiwinsten: Er wordt verwacht dat BBBY binnen 3 jaar winstgevend zal worden.

Omzet versus markt: De omzet van BBBY ( 8.9% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 11.6% per jaar).

Hoge groei-inkomsten: De omzet van BBBY ( 8.9% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van BBBY naar verwachting over 3 jaar hoog zal zijn


Ontdek groeibedrijven

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/05/11 16:12
Aandelenkoers aan het einde van de dag2026/05/08 00:00
Inkomsten2026/03/31
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Bed Bath & Beyond, Inc. wordt gevolgd door 13 analisten. 3 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Seth SigmanBarclays
Daniel KurnosBenchmark Company
Curtis NagleBofA Global Research